Nephros (NEPH) vs Sensus Healthcare (SRTS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Sensus Healthcare (SRTS) has outperformed Nephros (NEPH) over the past year, losing 13.2% versus a loss of 34.6%. Over five years, SRTS leads with a -25.6% price change compared with -54.5% for NEPH. Sensus Healthcare is the larger company by market cap ($48.6 million vs $38.3 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NEPH | SRTS |
|---|---|---|
| Share price | $3.53 | $2.95 |
| Market cap | $38.34M | $48.56M |
| 1-day change | +7.29% | -0.67% |
| YTD return | -27.66% | -25.88% |
| 1-year return | -34.63% | -13.24% |
| 5-year return | -54.51% | -25.56% |
| P/E ratio (TTM) | 22.06 | — |
| Forward P/E | 16.81 | — |
| EPS (TTM) | $0.16 | $-0.92 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.42 | $5.49 |
| 52-week low | $2.66 | $2.66 |
| Distance from 52-week high | -45.02% | -46.27% |
| Analyst consensus | none | none |
| Avg. price target upside | +77.05% | +82.37% |
| Average volume | 27.59K | 29.59K |
| Shares outstanding | 10.86M | 16.46M |
| Employees | 36 | 60 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- SRTS has outperformed NEPH by 21.4 percentage points over the past year.
About Nephros
NEPH stock →Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in foodservice and hospitality, and other healthcare facilities.
Health Care · Medical/Dental Instruments · 36 employees
About Sensus Healthcare
SRTS stock →Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide.
Health Care · Medical/Dental Instruments · 60 employees
NEPH vs SRTS FAQ
Which is bigger, Nephros or Sensus Healthcare?
Sensus Healthcare (SRTS) is larger, with a market capitalization of $48.56M compared with $38.34M for Nephros (NEPH).
Which stock has performed better over the past year, NEPH or SRTS?
SRTS returned -13.24% over the past 12 months, compared with -34.63% for NEPH (price return, excluding dividends). Past performance does not predict future results.
Are Nephros and Sensus Healthcare in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.